T. Rowe Price Associates
VXRT

T. Rowe Price Associates’s Vaxart VXRT Stock Holding History

T. Rowe Price Associates’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-78,500
Closed -$67K – 3061
2024
Q3 		$67K Hold
78,500
– – ﹤0.01% 2890
2024
Q2 		$52K Hold
78,500
– – ﹤0.01% 2849
2024
Q1 		$103K Hold
78,500
– – ﹤0.01% 2777
2023
Q4 		$45K Hold
78,500
– – ﹤0.01% 2824
2023
Q3 		$60K Hold
78,500
– – ﹤0.01% 2753
2023
Q2 		$58K Sell
78,500
-23,480
-23% -$21.8K ﹤0.01% 2786
2023
Q1 		$78K Buy
101,980
+22,500
+28% +$20.9K ﹤0.01% 2730
2022
Q4 		$76K Buy
79,480
+4,176
+6% +$5.9K ﹤0.01% 2762
2022
Q3 		$165K Sell
75,304
-88,114
-54% -$304K ﹤0.01% 2606
2022
Q2 		$572K Buy
163,418
+84,700
+108% +$316K ﹤0.01% 2167
2022
Q1 		$397K Buy
78,718
+11,321
+17% +$57.3K ﹤0.01% 2440
2021
Q4 		$423K Sell
67,397
-10,637
-14% -$72.6K ﹤0.01% 2466
2021
Q3 		$620K Sell
78,034
-16,600
-18% -$137K ﹤0.01% 2274
2021
Q2 		$709K Buy
94,634
+12,090
+15% +$84.4K ﹤0.01% 2215
2021
Q1 		$499K Sell
82,544
-1,135,953
-93% -$8.74M ﹤0.01% 2367
2020
Q4 		$6.96M Buy
1,218,497
+493,154
+68% +$3.14M ﹤0.01% 1397
2020
Q3 		$4.82M Buy
+725,343
New +$6.46M ﹤0.01% 1407

Other funds holding VXRT

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates's VXRT Position: Q4 2024 in Review

T. Rowe Price Associates sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 78,500 shares — an estimated $67K sold.

T. Rowe Price Associates first reported a position in VXRT in Q3 2020 and held it in 17 quarters. The position peaked at $6.96M in Q4 2020. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

  • T. Rowe Price Associates reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 78,500 Vaxart shares in Q4 2024, an estimated $67K.
  • T. Rowe Price Associates first reported a position in Vaxart in Q3 2020 and held it in 17 quarters.
  • T. Rowe Price Associates's Vaxart position peaked at $6.96M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.